Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7585220.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transforming growth factor beta 1 (TGF-beta 1) is a platelet-derived cytokine involved in both normal wound healing and scarring. We show that human platelets contain two pools of latent TGF-beta 1, which constitute more than 95% of the total TGF-beta assayed in whole platelets. During clotting, one pool, the large latent TGF-beta complex consisting of latent TGF-beta binding protein (LTBP), the latency-associated peptide (LAP) and the 25-kD mature TGF-beta 1 dimer is released into the serum. A second pool, which contains LAP but not LTBP, is retained in the clot, but can be released by RGD peptide. When the clot is dissolved by plasmin this bound TGF-beta 1 is gradually activated and released. If similar mechanisms operate in vivo, the clot will act as a slow-release capsule of TGF-beta 1 activity during wound healing.
Medical subject headings
- Blood Platelets
- Carrier Proteins
- Fibrinolysin
- Fibrinolysis
- Intracellular Signaling Peptides and Proteins
- Peptide Fragments
- Protein Precursors
- Proteins
- Transforming Growth Factor beta